Careless use of drugs bred baby-threatening germ, scientists report

August 4, 2014
Credit: Anna Langova/public domain

Careless use of a broad-spectrum antibiotic in the 1950s created a "hyper-virulent" strain of germ that worsened risks for newborn babies, according to detective work by French-led gene scientists.

Today's strain of Streptococcus agalactiae results from massive over-use of in the post-World War II antibiotics boom, they reported in the journal Nature Communications on Monday.

Strains of the microbe that were sensitive to tetracycline were wiped out, leaving behind a dominant, resistant superstrain that is dangerous for newborn babies without careful preventive care.

S. agalactiae is a common bacterium that colonises the intestines or urinary-genital tract. Between 15 and 30 percent of people carry the germ but the vast majority of them do not fall ill from it.

But the bacterium can be dangerous to newborns if they are exposed to it through infected fluids during delivery, be it vaginal or caesarean.

Called Group B Strep (GBS), infection can lead to potentially fatal pneumonia, meningitis and blood infection.

The new study unravelled the genetic code of 229 samples of S. agalactiae dating from 1950 to the present day, enabling the scientists to draw up a family tree of the bug and its evolution.

The probe revealed a "hypervirulent" strain called CC17 that began to emerge in the early 1960s, also coinciding with a worrying surge in GBS cases in America and Europe, affecting roughly one in three births.

"The use of tetracycline from 1948 onwards led in humans to the complete replacement of a diverse GBS population by only (a) few tetracycline-resistant clones, particularly well adapted to their host," the paper said.

Ninety percent of S. galacticae found in human samples are of this resistant strain, it found.

Lead investigator Philippe Glaser of France's Pasteur Institute said, "The impact (of tetracycline abuse) is being felt today, even though tetracycline is no longer in general use."

The risk from GBS is fought by screening the mother-to-be for the germ through swab samples from the vagina and rectum.

Doctors usually prescribe safe oral antibiotics such as penicillin or cephalexin to kill the streptococcus before delivery. In western countries, GBS infections today roughly once in every 2,000 births.

In a press release, the Pasteur Institute said the investigation highlighted the peril of mindless use of antibiotics.

"Tetracycline was handed out preventatively or for treatment for a wide range of diseases," it said.

"Today multi-resistant bacteria is a major problem, so this study shows the need to take into account the impacts from all prescribed antibiotics, not just in terms of the direct risk of resistance, but also on normal bacterial flora."

Explore further: More accurate diagnostic test may reduce deaths

Related Stories

More accurate diagnostic test may reduce deaths

June 26, 2012
A more accurate, faster diagnostic test for Group B Streptococcal infection in babies has been reported in the Journal of Medical Microbiology. The new test could allow better treatment and management of the disease and reduce ...

New research has shown that the burden of meningitis in babies unchanged in 25 years

July 16, 2014
New research by Professor Paul Heath funded by Meningitis Research Foundation has shown that the burden of meningitis in babies under three months of age has changed little in the past 25 years.

New survey launched into Group B streptococcus infection in babies

April 2, 2014
Researchers have launched a national study to see how common the potentially fatal bacterial infection Group B streptococcus is in UK and Irish babies.

Is there a way to slow the process of bacterial antibiotic resistance?

April 10, 2014
Continually under attack by noxious substances in their environments, bacteria have developed many clever mechanisms to survive. When confronted with an antibiotic, they can destroy it with enzymes, rendering it harmless. ...

The effectiveness of antibiotics in treating cholera

June 19, 2014
Researchers from the Cochrane Infectious Diseases Group, co-ordinated through the editorial base in LSTM, conducted an independent review of the effects of treating cholera with antimicrobial drugs, published in The Cochrane ...

Emerging antibiotic resistance in Listeria

January 24, 2013
Malaysian researchers have revealed the presence of multidrug-resistant strains of Listeria monocytogenes in frozen burger patties taken from supermarkets and other retail shops in Malaysia. The research was published in ...

Recommended for you

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

Can previous exposure to west Nile alter the course of Zika?

August 15, 2017
West Nile virus is no stranger to the U.S.-Mexico border; thousands of people in the region have contracted the mosquito-borne virus in the past. But could this previous exposure affect how intensely Zika sickens someone ...

Compounds in desert creosote bush could treat giardia and 'brain-eating' amoeba infections

August 15, 2017
Researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego and the University of Colorado Anschutz Medical Campus have found that compounds produced by the creosote bush, a ...

New malaria analysis method reveals disease severity in minutes

August 11, 2017
Left untreated, malaria can progress from being mild to severe—and potentially fatal—in 24 hours. So researchers at the University of British Columbia developed a method to quickly and sensitively assess the progression ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

cabhanlistis
not rated yet Aug 05, 2014
In a press release, the Pasteur Institute said the investigation highlighted the peril of mindless use of antibiotics.

This reminds me of a doctor who would throw pills at me for the tiniest complaint. Maybe they're susceptible to some kind of prescription addiction.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.